Structural insights into ligand recognition and activation of the melanocortin-4 receptor
Huibing Zhang,Li-Nan Chen,Dehua Yang,Chunyou Mao,Qingya Shen,Wenbo Feng,Dan-Dan Shen,Antao Dai,Shanshan Xie,Yan Zhou,Jiao Qin,Jin-Peng Sun,Daniel H. Scharf,Tingjun Hou,Tianhua Zhou,Ming-Wei Wang,Yan Zhang
DOI: https://doi.org/10.1038/s41422-021-00552-3
IF: 44.1
2021-08-25
Cell Research
Abstract:Melanocortin-4 receptor (MC4R) plays a central role in the regulation of energy homeostasis. Its high sequence similarity to other MC receptor family members, low agonist selectivity and the lack of structural information concerning MC4R-specific activation have hampered the development of MC4R-seletive therapeutics to treat obesity. Here, we report four high-resolution structures of full-length MC4R in complex with the heterotrimeric Gs protein stimulated by the endogenous peptide ligand α-MSH, FDA-approved drugs afamelanotide (Scenesse™) and bremelanotide (Vyleesi™), and a selective small-molecule ligand THIQ, respectively. Together with pharmacological studies, our results reveal the conserved binding mode of peptidic agonists, the distinctive molecular details of small-molecule agonist recognition underlying receptor subtype selectivity, and a distinct activation mechanism for MC4R, thereby offering new insights into G protein coupling. Our work may facilitate the discovery of selective therapeutic agents targeting MC4R.
cell biology